Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEH113 for Menstrual Cramp Pain in Primary Dysmenorrhea
NCT06268054Phase 3Not yet recruiting
- Sponsor
- EMS
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in primary dysmenorrhea (PD) comparing DEH113 with Placebo (2 arms). Primary endpoint: Sum of Total Pain Relief over 0-6 hours post-dose. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dexibuprofen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06268054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06268054.